神经调节和功能性胃肠道疾病
Shuhui Zhang1, Can Zhang1, Mingwei Fan1
1Department of Gastroenterology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Neuromodulation : journal of the International Neuromodulation Society
|September 10, 2023
概括
神经调节为功能性胃肠道疾病 (FGIDs) 提供了有前途的治疗方法. 本综述探讨了各种神经调节技术,包括电和神经刺激,以改善FGID管理.
科学领域:
- 胃肠病学 胃肠病学
- 神经学 神经学
- 医疗器械 医疗器械
背景情况:
- 功能性胃肠道疾病 (FGIDs) 很普遍,严重影响患者的生活质量.
- 目前对FGID病原体和有效治疗方法的理解仍然有限.
- 神经调节是一种新兴的治疗策略,证明了FGIDs的有效性.
研究的目的:
- 审查FGID神经调节的历史发展.
- 检查用于FGID治疗的神经调节技术的最新进展.
- 讨论神经调节的关键方面,包括参数选择和机制.
主要方法:
- 使用PubMed.com进行系统的文献审查.
- 对FGIDs的历史和当代神经调节方法的分析.
- 综合关于疗效,机制和未来研究方向的发现.
主要成果:
- 各种神经调节方法对FGIDs表现出改善的效果.
- 技术包括电针,神经刺激,圣神经刺激 (SNS) 和胃电刺激.
- 像SNS-tibial神经刺激和穿皮电刺激这样的非侵入性选择正在出现.
结论:
- 神经调节为管理FGID提供了一个可行的治疗途径.
- 需要进一步的研究来优化刺激参数并阐明潜在的机制.
- 未来的方向包括完善现有技术和探索新的神经刺激方法.
相关概念视频
Gastrointestinal Motility Disorders
425
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
425
Enteric Nervous System: Regulation of GI Motor Activity
441
The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
441
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
297
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
297
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
378
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
378
Irritable Bowel Syndrome III: Medical and Nursing Management
237
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
237
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K


